Answers are grounded in this paper and cite their sources.
Objectives: To characterize completion of fecal elastase-1 (FE-1) testing, identify clinical contexts associated with abnormal results, evaluate downstream diagnostic and treatment events, and determine the clinical significance of non-completion. Methods: We conducted a retrospective cohort study of adults with FE-1 orders from 2017 through 2022 in a large integrated health system. Orders placed within 30 days were consolidated into diagnostic episodes. Completion required a linked specimen with a reported result. We evaluated pre-order clinical contexts and one-year outcomes and performed a weighted manual chart review of 200 unique patients with non-completed episodes sampled from four downstream pathway strata. Results: Among 23,422 diagnostic episodes, 11,834 (50.5%) were completed. FE-1 ≤200 µg/g occurred in 20.4% of interpretable results and varied by clinical context: 13.7% with irritable bowel syndrome, 21.2% with chronic diarrhea, 38.3% with chronic pancreatitis, 60.1% with pancreatic cancer, and 79.5% after pancreatic surgery. Initial completion was associated with higher odds of new exocrine pancreatic insufficiency diagnosis (adjusted odds ratio, 2.27; 95% confidence interval, 1.91–2.70) and pancreatic enzyme replacement therapy initiation (adjusted odds ratio, 2.20; 95% confidence interval, 1.89–2.55), whereas non-completion was associated with more repeat FE-1 testing. Among eligible unique non-completers, weighted chart review classified 66.9% as probable missed diagnostic follow-through based on available documentation; failure to submit or return the specimen (60.1%) and specimen-processing problems (20.4%) predominated. Conclusions: FE-1 completion was modestly associated with measured pre-order factors, while abnormal results varied substantially by clinical context. Specimen return, processing, and closed-loop follow-up represent potential targets for improving evaluation of exocrine pancreatic insufficiency.
No takes yet. Share an insight, caveat, or question.
Chatterjee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: